To evaluate the safety and efficacy of ultrasonography (US) -guided radiofrequency ablation for liver tumors, the investigators used preoperative and postoperative US/CEUS(contrast-enhanced ultrasonography)/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
400
The investigators used percutaneously US-guided radiofrequency ablation for patients with small hepatocellular carcinoma,and estimated the safety and efficacy of this treatment through 2-year follow-up of US/CEUS/CT/MRI and the tumor markers.
The First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China
RECRUITINGTumor size assessed by MRI
Tumor size was estimated by MRI.
Time frame: through study completion, an average of 2 year
Carcinoembryonic Antigen (CEA) level assessed by ELISA
CEA level was assessed by enzyme linked immunosorbent assay (ELISA).
Time frame: through study completion, an average of 2 year
Alpha Fetoprotein (AFP) level assessed by ELISA
AFP level was assessed by ELISA.
Time frame: through study completion, an average of 2 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.